Wireless carriers woke up to an unwelcome surprise from a very unlikely rival, while a corner of healthcare caught a surprisingly hopeful tailwind out of Washington. Meanwhile, one big airline admitted the summer ran pricier than planned.
The common thread across all three is well worth knowing before the weekend, so read on and see how it all fits together.
Tax Strategy (Sponsored)
Capital gains taxes can take a bigger bite out of your profits than expected.
Fortunately, some deductions may help reduce the impact — including:
Investment-related expenses
Certain real estate selling costs
Because rules and eligibility vary, many investors turn to fiduciary financial advisors for guidance.
Find an Advisor Match.
Markets
Wireless carriers endured a day of woe after SpaceX struck an 8-billion-dollar spectrum deal, its boldest move yet into mobile service, leaving the big players headed for their worst drops in over a decade.
Vaccine makers took the opposite path after a report that the NIH will launch a public-private push on personalized cancer vaccines in December.
Delta trimmed its earnings outlook, blaming persistently high fuel costs, and Brent stayed above 100 dollars as reports of struck ships near Hormuz kept traders edgy.
The dollar is on pace for a fourth straight weekly gain as investors price in more Fed hikes. Meanwhile, small caps are chasing a fifth straight losing week. Trump also scheduled a November 5 White House hearing for Fed governor Lisa Cook.
DJIA: [+0.83%]
S&P 500: [+0.59%]
Nasdaq: [+0.64%]
Russell 2000: [+0.52%]
Market-Moving News
Auto & Aviation
Tesla renamed its Full Self-Driving feature Tesla Assisted Driving on European websites, dropping terminology regulators considered misleading as it pursues broader approval for software that still requires constant driver supervision.
Delta Air Lines cut its annual profit forecast by nearly a quarter, as an expected $6 billion increase in fuel costs outweighs higher ticket prices and strong travel demand, despite support from its refinery.
Smartphones & Semiconductors
Apple reportedly cut October component orders for its iPhone 18 Pro lineup by 15% to 20%, as higher prices weighed on demand, according to Nikkei Asia reporting covered by Yahoo Finance.
Qualcomm’s licensing dispute with Arm was set to reach a jury Friday, with allegations involving withheld design tools and interference in Meta dealings; Arm argues Qualcomm suffered no harm from the alleged conduct.
Media & Telecom
Cable One faces a lawsuit seeking to block its roughly $480 million purchase of a majority stake in Mega Broadband, with lender CoBank alleging the transaction threatens its financial position.
Netflix reportedly plans to cut about 5% of its workforce, with an announcement expected as early as next week, according to Puck News, while the streaming company declined to comment on the reported layoffs.
Seven Picks Selected (Sponsored)
Only a tiny percentage of stocks meet the criteria for this report.
Analysts have released a new edition highlighting seven names selected using multiple indicators.
Recent picks have delivered notable short-term gains, though results can vary.
The latest report is now available for a limited time.
Download the free report today.
*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.
Biotech & Drug Development
BioMarin announced new research examining Voxzogo’s effects on skull growth in children with achondroplasia, including imaging findings from a clinical trial analysis, as it prepares to present 13 studies at a major bone research conference.
HCW Biologics received FDA guidance for developing its experimental solid-tumor treatment HCW11-018b, with manufacturing of clinical trial supplies underway and an application to begin human testing planned for the first half of 2027.
Aerospace & Defense
Microchip acquired VORAGO Technologies to expand its aerospace and defense chip portfolio, adding processors designed to withstand radiation and extreme temperatures for military and space applications, with financial terms undisclosed.
Booz Allen’s autonomy software is being integrated into Performance Drone Works’ military drones, enabling missions with reduced manual control while operators retain decision authority, with general availability planned for early 2027.
Top Winners and Losers
WF Holding [WFF] $12.29 (+499.51%)
WF Holding rocketed roughly sixfold in one session with no company news to explain it. The Malaysia-based fiberglass tank and ducting maker listed in 2025 did a one-for-five reverse split in April, and lined up a $30 million equity line this summer.
A small name with that much financing paperwork on file tends to move in bursts.
Cue Biopharma [CUE] $27.66 (+23.87%)
Cue Biopharma extended a rebound that traces back to September, when its CUE-221 trial in chronic hives showed complete hive resolution in 43 to 54 percent of patients versus 11 percent on placebo.
A friendly biotech tape helped, with drug and vaccine developers broadly higher today. Investors are still paying for data that arrived three weeks ago.
Kailera Therapeutics [KLRA] $11.61 (+16.10%)
Kailera Therapeutics climbed with biotech’s broad bounce, lifting the obesity drug developer back above $11 after it closed near $10 on Thursday.
Its GLP-1 candidate, ecnoglutide, remains the long-term story for investors, and analysts lean bullish, with six of eight tracked ratings at Buy or better. Sector momentum seems to have done the heavy lifting here.
Cable One [CABO] $11.14 (-27.57%)
Cable One tumbled after lender CoBank moved to block its planned purchase of a 55 percent stake in Mega Broadband, a deal that requires a $480 million payment.
CoBank, which holds $1.1 billion in secured credit to the company, argues the acquisition could worsen already strained finances. It is a sharp reversal from yesterday’s relief rally on refinancing hopes.
Chaince Digital Holdings [CD] $8.66 (-20.62%)
Chaince Digital gave back Thursday’s gains and then some, in a stock that swung between roughly $9 and $12.60 just a day earlier.
The tokenization-focused firm is a high-wire act, with an August registered direct offering adding about 30 million shares and a beta that makes roller coasters look sleepy. Fast money rotates quickly in names like this.
BayFirst Financial [BAFN] $5.38 (-19.94%)
BayFirst Financial slid as the Florida bank keeps wrestling with a rough year, including a second-quarter loss of roughly $33 million tied to one-time charges.
A discounted rights offering priced at $3.50 per share also hangs over the stock. Third-quarter results arrive on October 29, and investors seem to be bracing for them.
The historically observed (though weakening) tendency for small-cap stocks to outperform in early January is known as:
Entry Exit Included (Sponsored)
Every trade answers three questions. Which stock? What entry price? Where to sell? One text covers all three.
Send me all three answers.
A live countdown runs on the Good Morning Alerts page. When it ends, a single stock gets chosen and texted to your phone.
Get me the entry and exit.
A name alone is not a plan. The entry and the exit are what turn it into a trade you can judge.
Yes, text me the trade.
*This ad is sent on behalf of Guardian Financial Publishing LLC, doing business as Stable Financial Publishing, 1013 Centre Road Suite 403-D, Wilmington, DE 19805. Nothing here is investment, financial, legal, or tax advice, and it is not a recommendation or solicitation to buy or sell any security. Investing involves substantial risk, including loss of principal; past performance does not guarantee future results. Trading small-cap and low-priced stocks involves substantial risk, including the possible loss of your entire investment. Stable Financial Publishing, its owners, employees and contributors may hold positions in securities mentioned and may trade them at any time. Privacy: https://guardian.pub/privacy-policy/ · Terms: https://guardian.pub/terms-of-service/
Everything Else
🎖️ The Magnificent Seven earned their reputation but market leadership never stays concentrated forever and seven new contenders are already emerging quietly with the fundamentals to lead what comes next.
📈 Wall Street headed toward weekly gains as tech shares rebounded, helping stocks recover after renewed concerns around OpenAI revenue prospects pressured the Nasdaq.
💼 The U.S. froze green cards for Microsoft and other IT firms, escalating scrutiny of employer participation in the permanent residency program.
🛢️ Hurricane Isaias disrupted U.S. oil production in the Gulf of Mexico and threatened refineries, raising fresh concerns over energy supply and refining operations.
💵 The dollar headed for a fourth straight weekly gain as the euro weakened, with fiscal concerns in Europe adding pressure to the single currency.
🤖 The AI-driven U.S. stock bull market is nearing its four-year anniversary, with technology shares remaining a major force behind Wall Street’s long-running advance.
You Read This Far. Here's Where the Real Work Lives.
We run three live portfolios on Autopilot, and everything about them is public: every position, every allocation, every trade, visible the moment it happens.
We keep our own money in each one, because analysis you won't fund yourself is just content.
THE UNBREAKABLE STACK
Our growth book: durable software and cybersecurity names built to compound quietly for years.
THE HORMUZ PREMIUM
Our energy thesis: built for how that sector actually pays, over quarters, not headlines.
THE ELON INDEX
Our conviction bet on the Musk universe: Tesla, and the companies orbiting his ventures, energy, AI, infrastructure. High-beta by design, for investors who want direct exposure to the trade rather than watching it from the sidelines.
And here's the part that makes it effortless: Autopilot does the trading for you. Connect the brokerage you already use (Robinhood, Schwab, Fidelity, and more) and every move we make gets mirrored in your own account automatically.
Your money never leaves your brokerage. It stays in your account, under your control, and you can override any trade or disconnect anytime. Autopilot even rebalances automatically when allocations drift, and you get a notification every time something happens.
No watching tickers. No timing entries. No fat-finger mistakes at market open. You pick the portfolio, we do the work, your account follows along.
Pick the one that fits your risk level, or run all three:
Live portfolios, real positions, our own capital at stake. Your funds stay in your own brokerage account. Past performance doesn't guarantee future results.
That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!
Thanks for reading. I'll see you at the next open!
Best Regards,
— Adam G.
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
